Phenylalanine hydroxylase [L-phenylalanine,tetrahydropteridine :oxygen oxidoreductase (4-hydroxylating); E C 1.14.16.11 catalyses the first reaction in the irreversible catabolism of the essential amino acid phenylalanine. Studies of the isolated enzyme and of phenylalanine metabolism in viuo and in oitro support the view that the hydroxylase plays the major role in regulating phenylalanine disposal under many conditions.
Phenylalanine and tyrosine (the immediate end product of hydroxylase activity) are both required for protein synthesis and probably share a single mechanism for entry into tissues. It is of some importance, therefore, that the balance between the concentrations of the two amino acids is maintained as physiological conditions change. The implication is that the activities of phenylalanine hydroxylase and of tyrosine aminotransferase (EC 2.6.1.9, the enzyme which initiates the oxidation of tyrosine, must be closely co-ordinated in vivo.
In liver extracts, the activity of phenylalanine hydroxylase, as measured with optimal concentrations of a synthetic pteridine substrate and phenylalanine, is relatively high (2-3pmol/min per g wet wt. of tissue). Were such activity to be expressed in viuo, the body's reserve of phenylalanine would be rapidly depleted. In practice, however, the rate with the natural pteridine, tetrahydrobiopterin, is less than 10% of this 'maximum' (Kaufman, 1971) and the low concentration of phenylalanine in the cell ensures that the rate is further decreased by an order of magnitude (Carr & Pogson, 1981) . The concentrations of the two substrates are therefore important determinants of enzyme activity in vivo, although the precise role of the pteridine remains to be clarified (Milstien & Kaufman, 1975) . In vitro, phenylalanine hydroxylase is phosphorylated by the cyclic AMP-dependent protein kinase (Abita et al., 1976; Donlon & Kaufman, 1980) and this phosphorylation has been shown in vivo (Donlon & Kaufman, 1978) and in liver cells (Abita et al., 1980) on exposure to glucagon. Changes in the activity of the enzyme expressed during incubation of cells with glucagon are only appreciable at low phenylalanine concentrations. Consistent with this, Shiman et al. (1982) suggest that phosphorylation does not activate the enzyme per se, but rather sensitizes it to the effect of phenylalanine acting as a stimulator at a site distinct from the catalytic site. It is apparent, however, that a phosphorylation-dephosphorylation cycle is potentially important in regulating the response of the enzyme to external stimuli, at least in the rat; the enzyme in human liver is reported not to undergo phosphorylation (Abita et al., 1983) . Other relevant factors include, in the short term, the availability of iron to the liver cell (Shiman & Jefferson, 1982) and, over longer periods, changes in the enzyme's total activity (Carr & Pogson, 1981 ; Donlon & Beirne, 1982) which parallel changes in hydroxylase protein concentration (M. A. Santana & C. I. Pogson, unpublished work) . We have studied the relationship between phosphorylation of the enzyme and metabolic flux in simultaneous liver cell incubations. Guroff & Abramowitz (1967) works remarkably cleanly with isolated liver cell incubations, with the modification that allowance must be made for the detritiation of [3-3H] tyrosine by further metabolism to homogentisate and beyond. Unreacted labelled substrate is readily removed by adsorption on to activated charcoal, so that flux through phenylalanine hydroxylase can be conveniently measured in large numbers of simultaneous equivalent cell incubations.
The extent of phosphorylation of the hydroxylase is determined from radioactivity incorporated into the precipitate obtained by treating cell extracts with monospecific anti-hydroxylase antibody. The amount of hydroxylase in the extract and the specificity of the antibody is such that it is necessary neither to add carrier nor to purify immunoprecipitates further.
By using these techniques we have succeeded in showing that the extent of phosphorylation of the enzyme closely parallels the changes in flux when cells are incubated with varying concentrations of glucagon Pogson et al., 1984) . Phosphorylation thus seems to be the only mechanism through which glucagon action is expressed.
Similar experiments have been performed to investigate whether other agents known to act by phosphorylation mechanisms also affect phenylalanine hydroxylase. As expected, dibutyryl cyclic AMP is effective, with half the maximal effect being seen at 5 x 1 0 -6~. It has been claimed that adrenergic agents may act in three ways on this system: directly (Miller & Shiman, 1976) , through a fl-mechanism (Abita et al., 1980) or through an a-mechanism (Garrison, 1983; Garrison et al., 1984) . In adult male rats, a-receptors predominate in the liver (Studer & Borle, 1982) ; we have found that, in cells from these animals, adrenergic agents stimulated both flux and phosphorylation, and that these effects were reversed by the a-blocker, phentolamine, but not by fl-blockade (Fisher etal., 1984) . In contrast, the livers of young male rats have an appreciable proportion of /Ireceptors (Blair et al., 1979) . Cells from such animals also respond to adrenergic agents, but, in this case, the response is blocked by propranolol, a fl-blocker . The results suggest that the hydroxylase may be phosphorylated by both cyclic AMP-dependent kinase and Ca2+-dependent kinase (Exton, 1982) activities. Although the hormones angiotensin I1 and vasopressin are generally thought to act in a manner similar to that of a-adrenergic agents, we were unable to detect any action of vasopressin (lo-' M) on either the activity or the phosphorylation state of the hydroxylase, although glycogenolysis was clearly stimulated in parallel incubations. Other groups have reported similar disparities (Assimacopoulos-Jeannet et al., 198 I ; Garrison, 1983; Kneer & Lardy, 1983) .
Phorbol ester has no observable effect on the activity of phenylalanine hydroxylase in cells, a result suggesting that the enzyme is not a substrate for protein kinase C, and supporting less direct evidence presented by Garrison (Garrison, 1983; Garrison et al., 1984) . There is a good correlation between the extent of phosphorylation and changes in metabolic flux, whether the phosphorylation is brought about by cyclic AMP-or CaZ+-dependent mechanisms (Fisher & Pogson, 1985) . The relationship suggests that a single site may be phosphorylated by both kinases, although the possibility of more than one site has been raised (Parniak et al., 1981) .
In cell incubations, the amount of phosphate incorporated into each subunit of the hydroxylase is only approx. 0.60-0.75 mol/mol with maximally stimulating concentrations of glucagon or dibutyryl cyclic AMP. a-Adrenergic agents, however, stimulate phosphorylation to a maximum always less than that seen with glucagon (approx. 0.4-0.5mol/mol). Two questions arise: (1) why does phosphorylation not reach a level of l.Omol/mol?; and (2) why are aadrenergic agents less effective in this respect? The answer to the first question may lie in the balance between enzyme phosphorylation and dephosphorylation. It has recently been shown that dephosphorylation of the enzyme phosphorylated in oitro with cyclic AMP-dependent protein kinase appears to be very largely catalysed by protein phosphatase 2A (Alemany et al., 1984; Pelech et at., 1984) . The factors regulating the activity of this phosphatase have yet to be elucidated although there is a report of a macromolecular inhibitor (Ingebritsen ef al., 1983) . The difference between the actions of glucagon and a-adrenergic agents may lie in the effects of these agents on the rate of dephosphorylation; glucagon does indeed decrease the rate at which [32P]P,, added with the hormone, labels the enzyme, an observation consistent with a decrease in protein phosphate turnover . It is possible also that binding of substrates to the hydroxylase may influence the response to the enzyme to the different stimuli (Phillips & Kaufman, 1984) .
Insulin, when added alone to cell incubations, has no effect on phenylalanine hydroxylase activity. At appropriate concentrations, however, it will antagonize the stimulation of flux elicited by glucagon. This effect has at least a cytoplasmic component because the antagonism is seen equally when the stimulus is dibutyryl cyclic AMP (M. J. Fisher & C . I. Pogson, unpublished work) .
In cells from animals which are chronically diabetic, the basal activity of phenylalanine hydroxylase is increased approx. 100% (Carr & Pogson, 1981) . Glucagon stimulates activity in these cells, but the effects of adrenergic agents are abolished.
In recent studies we have been unable to confirm earlier reports that the hydroxylase activity in rat liver is decreased by starvation (Yuwiler et al., 1969) and increased by supraphysiological doses of tryptophan (Freedland et al., 1964) . Neither of these stimuli was associated with significant changes in assayable activity or with flux through the enzyme in cells . Fig. 1 outlines the mechanisms by which phenylalanine hydroxylase activity may be controlled in oioo.
K ynurenine hydroxylase [L-kynurenine,N ADPH : oxygen oxidoreductase (3-hydroxylating), EC 1.14.13.91 is a mixedfunction oxidase which catalyses the 3-hydroxylation of Lkynurenine, an intermediate in the oxidative metabolism of tryptophan. It is a flavoprotein, and is located in the outer mitochondria1 membrane. Either NADPH or NADH will act as the electron donor: when NADPH is the co-substrate, the K , for kynurenine is slightly lower, and the V,,,, of the reaction slightly higher, than with NADH. The K, for NADPH is 0.25 x 1 0 -J~, compared with 0.5 x 1 0 -4~ for NADH (Shibata, 1978) .
The purified enzyme exists as an oligomer in aqueous media. The monomer has an M , of 160000, and only about 10% of the catalytic activity of the dimer (Nisimoto et al., 1977) . The enzyme contains four mol of FAD per monomer. The apoenzyme can only be partially re-activated by incubation with FAD, suggesting that binding of the prosthetic group involves a considerable conformational change. The apparent K , for FAD is 1.12 x IO-'M, and there is no evidence of co-operativity in the binding of the four mol of FAD: the double reciprocal plot of activity versus FAD is linear. Kynurenine hydroxylase is unusual among flavoproteins in that the fluorescence of the prosthetic group in the holo-enzyme is five to six times greater than that of free flavin nucleotides, suggesting that the binding of FAD in this enzyme is different from that in most flavoproteins (Nisimoto et al., 1977) .
The rate-limiting enzyme of the oxidative metabolism of tryptophan is generally considered to be tryptophan oxygenase (L-tryptophan :oxygen oxidoreductase, EC 1.13.1 I . 1 I). the first enzyme of the pathway (Fig. 1) . However, Knox (1953) noted that when the activity of the oxygenase was increased, for example after induction by glucocorticoid hormones, the activity of kynureninase (Lkynurenine hydrolase, EC 3.7.1.3) became limiting for flux of metabolites through the pathway.
The K , for kynurenine of partially purified kynurenine hydroxylase from rat liver is 18 k 6 p~, compared with a steady-state concentration of kynurenine in the liver of 4.9 * 0 . 9 p~, suggesting that under normal conditions the enzyme acts somewhat below its maximum rate, and therefore has some capacity for increased activity as the hepatic concentration of kynurenine increases (Bender & McCreanor, 1982) .
From the values of K , and V,,,,,. for kynurenine hydroxylase and kynureninase, and knowing approximate steady-state concentations of kynurenine and hydroxykynurenine in the liver, it is possible to calculate that the normal steady-state rate of kynurenine hydroxylation is 0.96 nmol/ min per g of liver, while the rate of hydrolysis of hydroxykynurenine by kynureninase is slightly higher, 1.3 nmol/min per g of liver. Therefore kynurenine hydroxylase is more likely than kynureninase to provide a secondary rate-limiting reaction of the pathway.
Kynurenine hydroxylase is inhibited by xanthurenic acid, the product of transamination of hydroxykynurenine. Since transamination is only an important route of metabolism of kynurenine and hydroxykynurenine when they are present in relatively high concentrations, this will provide an indirect feedback control of kynurenine hydroxylation (Shibata, 1978) . Such regulation of the formation of xanthurenic acid may be physiologically important, since xanthurenic acid forms a complex with insulin that is biologically inactive and may be a factor in oestrogenrelated glucose intolerance (Kotake et al., 1975) .
The oxidative pathway of tryptophan metabolism not only provides a route for total oxidation of tryptophan to acetyl-CoA, but is also the pathway for the synthesis de nooo of the nicotinamide nucleotide coenzymes, NAD and NADP. Animal studies suggest that synthesis de nouo is a more important source of the coenzymes than is the direct utilization of nicotinamide and nicotinic acid, derived from the diet or the hydrolysis of NAD(P) (Bender et al., 1982) . The extent of NAD(P) synthesis from tryptophan depends to a great extent on the rate of flux of metabolites through the oxidative pathway, since the formation of quinolinic acid, the immediate precursor of the nucleotides, is the result of non-enzymic cyclization of aminocarboxymuconic semialdehyde, in competition with enzyme-catalysed decarboxylation. Quinolinic acid is only formed in significant amounts when picolinate carboxylase is more or less saturated with its substrate (Ikeda et al., 1965) . It is therefore likely that any factor that modifies the flux of metabolites through the pathway will result in a disproportionately large change in the synthesis of the coenzymes. Under conditions where the dietary intake of tryptophan and niacin is marginal, any such inhibition may well precipitate clinical pellagra.
Measurement of the urinary excretion of kynurenine and hydroxykynurenine under various conditions should reflect the relative activity of kynurenine hydroxylase, assuming that tissue and renal clearance of both metabolites is the
